受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A4064
Vanucizumab is a humanized bispecific IgG1 antibody targeting VEGF-A and Ang-2 to inhibit tumor angiogenesis. It is being developed for the treatment of advanced solid tumors demonstrating anti-tumor, anti-angiogenic, and anti-metastatic effects. M.W 146.89 kDa
CAS No. | 1448221-05-3 |
---|---|
Source | CHO |
Storage (From the date of receipt) |
-80℃ |
Shipping | Shipped under low temperature conditions |
人間や獣医の診断であるか治療的な使用のためにでない。